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Background: To investigate the autoinflammatory hereditary periodic fever syndrome genes MVK and TNFRSF1A,
and the NLRP1 and IL1 genes, for association with juvenile idiopathic arthritis (JIA).
Methods: For MVK, TNFRSF1A and NLRP1 pair-wise tagging SNPs across each gene were selected and for IL1A SNPs
from a prior meta-analysis were included. 1054 UK Caucasian JIA patients were genotyped by Sequenom iPlex
MassARRAY and allele and genotype frequencies compared with 5380 unrelated healthy UK Caucasian controls.
Results: Four SNPs were significantly associated with UK JIA: rs2071374 within intron 4 of IL1A (ptrend=0.006),
rs2228576 3’ of TNFRSF1A (ptrend=0.009) and 2 SNPs, rs11836136 and rs7957619, within MVK (ptrend=0.006,
ptrend=0.005 respectively). In all cases the association appeared to be driven by the systemic-onset JIA (SoJIA)
subtype. Genotype data for the two MVK SNPs was available in a validation cohort of 814 JIA (oligoarticular and RF
negative polyarticular) cases and 3058 controls from the US. Replication was not confirmed, however, further
suggesting that this association is specific to SoJIA.
Conclusions: These findings extend the observations of the relevance of studying monogenic loci as candidates
for complex diseases. We provide novel evidence of association of MVK and TNFRSF1A with UK JIA, specifically
driven by association with SoJIA and further confirm that the IL1A SNP association with SoJIA is subtype specific.
Replication is required in independent cohorts.
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Juvenile idiopathic arthritis (JIA) is the most common
chronic rheumatic disease of childhood. It occurs, by
definition, before the age of 16 years, with a duration of
more than six weeks. JIA is a heterogeneous condition,
and has been divided into several subtypes based on
clinical features, family history, and laboratory markers
[1], though they all share chronic inflammation of one
or more synovial joints.
The contribution of common variants of genes, in which
mutations cause distinct, rare syndromes, to complex
oligogenic phenotypes is increasingly recognised [2-6].* Correspondence: Rachelle.donn@manchester.ac.uk
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reproduction in any medium, provided the orWe have previously described associations between
the psoriatic subtype of JIA and single-nucleotide poly-
morphisms (SNPs) in four genes responsible for mono-
genic hereditary periodic fever syndromes (HPFs) or
autoinflammatory syndromes [7]. The HPF syndromes
are a heterogeneous group of autoinflammatory diseases,
unified by the common feature of episodes of unpro-
voked inflammation, along with other signs of systemic
infection such as fever. Arthralgia or arthritis is often
part of the presenting form [8]. They are caused by aber-
rant activation of the innate immune system, a mechan-
ism that may also be relevant to JIA.
In the present study we have investigated the genes
implicated in two additional HPF syndromes. These are
MVK, located on chromosome 12q24, responsible for
hyper-IgD syndrome (HIDS), and TNFRSF1A, located
on chromosome 12p13.2, responsible for TNF receptor-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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HPF syndromes, is characterized by periodic inflamma-
tion, but has high serum IgD level and an array of
inflammatory symptoms including lymphadenopathy,
rash, gastrointestinal upset and arthritis [9]. Mutations
in MVK are also responsible for the severe monogenic
metabolic disorder mevalonic aciduria. TRAPS is the
most common autosomal dominant HPF syndrome and
is distinguished clinically by particularly long duration of
attacks. Arthralgia and non-erosive synovitis are among
the most common manifestations [10].
In addition, we have studied NLRP1, which encodes
NACHT leucine-rich-repeat protein 1, a regulator of the
innate immune system. NLRP1 provides a scaffold for the
assembly of the inflammasome that activates caspases 1
and 5, which subsequently promote the processing and
maturation of the inflammatory cytokines pro-IL-1β,
IL-18 and IL-33 [11]. NLRP1 is a homologue of NLRP3,
one of the genes found previously to be associated with
psoriatic JIA [7]. SNPs in NLRP1 have recently been asso-
ciated with vitiligo-associated autoimmune disease, auto-
immune Addison’s disease, and type 1 diabetes [12,13].
Interleukin 1 (IL-1) helps coordinate the immune
system’s early response to exogenous and endogenous
danger, serving as a prototypic alarm cytokine. Increased
production of IL-1 is thought to be a fundamental com-
ponent in the pathogenesis of the majority of the HPF
syndromes [14]. Furthermore, the systemic-onset sub-
type of JIA (SoJIA) has been classified, in recent years,
as an autoinflammatory disease. Leukocyte gene expres-
sion profiling of SoJIA patients identified a unique IL-1β
signature when compared to controls, and which
changed significantly following IL-1β blockade [15].
However, subsequent studies have failed to replicate the
IL-1β signature [16,17]. Stock et al. described association
between SoJIA and SNPs in the IL-1 ligand and IL-1
receptor clusters [18]. The relevance of these SNPs to
other JIA subtypes has not previously been investigated.
We have utilised a large collection of UK Caucasian
JIA samples and controls to determine SNP associations
with the autoinflammatory disease related loci MVK,
TNFRSF1A, NLRP1, IL1 ligand and IL1 receptor. Data
collected from a US genome wide association study of JIA
was available for validation of any significant findings.
Methods
Initial UK cohort - subjects
DNA was available for 1054 UK Caucasian JIA patients
(332 males: 715 females) from three sources. The British
Society for Paediatric and Adolescent Rheumatology
(BSPAR) National Repository of JIA (n=654), a cohort of
UK Caucasian patients with long-standing JIA (n=201),
described previously [19] and a third cohort collected
as part of the Childhood Arthritis prospective Study(CAPS), a prospective inception cohort study of JIA
cases from 5 centres across UK (n=199) [20]. JIA cases
were classified according to ILAR criteria [1]. The
numbers per subtype were: systemic onset (n=165), per-
sistent oligoarthritis (n=276), extended oligoarthritis
(n=143), rheumatoid factor (RF) negative polyarthritis
(n=208), RF positive polyarthritis (n=67), enthesitis
related JIA (n=64), psoriatic JIA (n=74) and unclassified
(n=57). Additional control DNA samples for genotyp-
ing (n=794) were recruited from blood donors, or from
the 1958 Birth Cohort (n=1717).
The SoJIA patients included in this present study are the
same as those previously reported on by Stock et al. [18].
All individuals were recruited with ethical approval
and provided informed consent [North-West Multi-
Centre Research Ethics Committee (MREC 99/8/84) and
the University of Manchester Committee on the Ethics
of Research on Human Beings].
SNP selection
Five loci were selected for analysis (MVK, TNFRSF1A,
NLRP1, IL1 ligand and IL1 receptor clusters).
For MVK, TNFRSF1A and NLRP1 pair-wise tagging
SNPs across each gene and within 10 kb 5’ and 3’ of it were
selected using HapMap release 22 (www.hapmap.ncbi.nlm.
gov) and the tagger function in Haploview version 4.1
(http://www.broadinstitute.org/haploview/haploview), using
an r2 cutoff ≥ 0.8 and MAF ≥ 0.05.
For the IL1 receptor and IL1 ligand clusters the four
SNPs that were previously associated in a two-stage
meta-analysis with SoJIA were selected for genotyping
[18]. In the IL1 receptor cluster, rs2190360, which has
r2=0.96 with rs12712122 was selected. In the IL1 ligand
cluster, the three SNPs were rs6712572, rs2071374 and
rs1688075.
Genotyping
SNP genotyping was performed using the Sequenom
iPlexW MassARRAY platform according to manufacturers
instructions (Sequenom, San Diego, CA. http://www.
sequenom.com/). A 90% sample quality control (QC) rate
and 90% SNP genotyping success rate was imposed on the
analysis.
Control genotyping data
All SNPs, except rs6712572, rs1688075 and rs1295288,
were genotyped as part of Wellcome Trust case control
consortium 2 (WTCCC2). Some SNPs have been geno-
typed using the Affymetrix platform, others the Illumina
platform and some have been genotyped on both, where
this is the case the Affymetrix control data has been used
preferentially, because of the larger cohort. Sample size
for the WTCCC2 Affymetrix control data =5380, for the
WTCCC2 Illumina control data =5200. The SNPs
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from blood donors and general practitioner records
(n=794) and rs1295288 was genotyped in 1958 Birth Co-
hort controls (n=1717).
Validation cohort
For validation of the findings in the UK cohort genotype
information was available from a replication cohort of 814
JIA cases and 3058 controls from the US. For the JIA chil-
dren, with polyarticular (RF negative) and oligoarticular
JIA, approximately 95% of the cases were recruited at the
Cincinnati Children's Hospital Medical Center (CCHMC)
or as part of a NIAMS supported JIA affected sibpair
registry. The remaining cases were contributed by collab-
orating centers which included Children's Hospital of
Wisconsin, Schneider Children's Hospital and Children's
Hospital of Philadelphia. The numbers per subtype were:
persistent oligoarthritis (n=343), extended oligoarthritis
(n=118) and rheumatoid factor (RF) negative polyarthritis
(n=353). The control cohort (n=3058) comprised 658
healthy children aged between 3–18 years, recruited from
the general population to represent the geographical
region served by CCHMC. In addition 2400 controls of
European ancestry were genotyped at the Broad Institute
on the Affymetrix SNP Array 6.0 as part of the Molecular
Genetics of Schizophrenia (MGS) genome wide associ-
ation study. Both cases and controls were run through
principal component analysis to look for outliers, and any
outliers excluded from analysis. SNPs were genotyped
using the Affymetrix Genome-Wide Human SNP Array
6.0. The study had full ethical committee approval
(CCHMC IRB) and was fully compliant with the Declar-
ation of Helsinki.
Statistical analysis
Power calculations were performed using QUANTO
[21], calculations assumed a log-additive model and
alpha value of 0.05. Genotype and allele frequencies were
compared between cases with JIA and controls using the
Cochrane-Armitage trend test implemented in PLINK
[22] and allelic odds ratios (ORs) and their 95% confi-
dence intervals (CIs) calculated. JIA is a phenotypically
heterogeneous disease and can be classified into more
clinically homogeneous diseases using the ILAR classifi-
cation criteria [1]. Therefore SNPs were also analysed
stratified by ILAR subtype, whereby each JIA subtype
was individually compared to controls. Conditional
logistic regression analysis was performed using PLINK.
Results
After QC the dataset for analysis from the initial UK
cohort comprised 1017 JIA cases and 5380 controls. Of
the 41 SNPs genotyped, 2 SNPs failed SNP QC in the
cases and 2 failed WTCCC2 control QC, these SNPswere dropped, leaving 37 SNPs for analysis. There was
an average coverage of all genes, after QC, of >86%.
This study had >80% to detect an effect >1.25 for
SNPs with allele frequencies >0.1.
Results for all SNPs studied in the total JIA group com-
pared with controls are presented in Additional file 1:
Table S1. The results for individual JIA subgroups com-
pared with controls are presented in Additional file 1:
Tables S2-S4.
Of the 37 SNPs analysed four show significant associ-
ation with JIA (Table 1). One SNP, rs2071374 in the IL1
ligand cluster showed significant association with JIA
(ptrend=0.006 OR 1.16 95% CI 1.04-1.30) (Table 1). The
association was with SoJIA (p=0.001 OR 1.5 95% CI
1.16-1.92). In addition, there was also a trend towards
association in the psoriatic subtype (p=0.11 OR 1.36 95%
CI 0.93-1.98). Odds ratio plot across all seven ILAR sub-
types is shown in Figure 1. Overall, three of the four
IL1-related SNPs tested in this study showed significant
association with SoJIA (Additional file 1: Table S2), and
when the dataset was reanalysed after removing the sys-
temic subtype none of the SNPs remained significantly
associated, further confirming the association as being
largely driven by the SoJIA subtype (Additional file 1:
Table S5). These SoJIA cases have been previously stud-
ied for the IL1-related SNPs by Stock et al. [18]. Our
data shows no evidence for significant association of the
IL1 ligand and IL1 receptor gene cluster with non SoJIA.
One SNP, rs2228576, at the 3’ end of the TNFRSF1A,
but which actually lies within the adjacent gene sodium
channel, non-voltage-gated 1 alpha (SCNN1A), was asso-
ciated with JIA (ptrend=0.009 OR 0.87 95% CI 0.78-
0.97) (Table 1).
Two SNPs in the MVK gene, rs1183616 (ptrend=0.006.
OR 1.17, 95% CI 1.04-1.30) and rs7957619 (ptrend=0.005
OR 1.23 95% CI 1.07-1.43) were associated with JIA
(Table 1). These two SNPs are in modest linkage disequi-
librium (r2=0.36, D’=1). Logistic regression of the two
SNPs, after conditioning on the most significant SNP,
found that the rs1183616 SNP was no longer significant
(p=0.3). This suggests that the association is a single effect
driven by the rs7957619 SNP. This SNP lies within exon 3
of the MVK gene and is a Serine to Asparagine substitu-
tion at position 52. Odds ratio plots for the rs7957619 and
the rs1183616 SNPs in the UK JIA subtypes are shown in
Figure 2a and b.
None of the 16 SNPs studied across the NLRP1 gene
locus were found to be associated with JIA susceptibility
(Additional file 1: Table S1).
Of the four significantly associated SNPs, only the two
SNPs in the MVK gene had genotype data available in a
validation cohort (US cases and controls). The SNPs in
the IL1 ligand and the TNFRSF1A genes were not geno-
typed on the Affymetrix array and there were no proxies
Table 1 SNPs significantly associated with JIA (p<0.05)
SNP CHR Position Gene Major allele
(allele 1)
Minor allele
(allele 2)
MAF
Case
MAF
Control
pHWE
Control
Case genotype frequencies Control genotype frequencies p-value Odds ratio
95% CI1/1 1/2 2/2 1/1 1/2 2/2
(%) (%) (%) (%) (%) (%)
rs2071374 2 113537352 IL1A A C 0.30 0.27 0.67 453 392 85 2751 2067 376 0.006 1.16 1.04-1.30
(48.7) (42.2) (9.1) (53.0) (39.8) (7.2)
rs2228576 12 6457062 TNFRSF1A G A 0.33 0.36 0.43 414 419 94 2136 2349 678 0.009 0.87 0.78-0.97
(44.7) (45.2) (10.1) (41.4) (45.5) (13.1)
rs11836136 12 110006512 MVK A G 0.29 0.26 1.00 460 380 74 2857 1992 347 0.006 1.17 1.04-1.30
(50.3) (41.6) (8.1) (55.0) (38.3) (6.7)
rs7957619 12 110013879 MVK G A 0.14 0.11 0.33 699 210 21 4099 1027 73 0.005 1.231.07-1.43
(75.2) (22.6) (2.3) (78.8) (19.8) (1.4)
CHR=chromosome, MAF=minor allele frequency, CI=confidence interval, pHWE= p-value for departure from Hardy-Weinburg equilibrium.
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Figure 1 Odds ratio and 95% CI plots for the IL1A SNP rs2071374 in UK JIA. Allele frequencies for each JIA subtype was compared with
that of the controls and the OR and 95% CI plotted. The comparison versus the total UK JIA cohort (All JIA) is also shown.
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http://www.ped-rheum.com/content/11/1/14(r2>0.8) for these SNPs. Of the two SNPs in the MVK
gene, one SNP, rs7957619, has been directly genotyped
and showed significant evidence for association with US
JIA (ptrend=0.04 OR 0.83 95% CI 0.7-0.99) (Table 2).
However, this association is in the opposite direction to
the association in UK JIA cases, where the minor allele
was associated with increased risk of developing JIA.
The second SNP, rs11836136, was not directly genotyped
on the array but a complete proxy, rs888193, showed no
association with JIA (ptrend=0.22) (Table 2).
Discussion
In this study we have utilised a large cohort of JIA cases
and identified associations between UK JIA and poly-
morphisms in three genes: MVK, TNFRSF1A, and IL1A.
These findings follow on from work performed by our
group, showing associations between psoriatic JIA and
other HPF syndrome genes, and work previously show-
ing associations between SoJIA and the IL1 ligand and
IL1 receptor gene clusters [7,18].
After applying a Bonferroni correction for the number
of loci studied (p<0.0013), none of the loci associated
with UK JIA would remain significant. However, this is a
highly conservative correction method which assumes
all tests are independent, as it does not take into account
correlations between SNPs. We have thus taken the
approach of trying to validate significant findings in an
independent cohort.
For two of the four significantly associated SNPs in
the UK cohort we had validation data from a US cohort.
One SNP showed no association in this cohort and the
other SNP showed association but in the opposite direc-
tion. The US cohort comprises JIA cases from only threeILAR subtypes: RF negative polyarthritis, persistent and
extended oligoarthritis subtypes, whereas the UK cohort
encompasses all seven of the ILAR JIA subtypes. Ana-
lysis of the UK dataset stratified by ILAR subtype for the
rs7957619 and rs11836136 SNPs suggests the association
with JIA overall is driven largely by the systemic,
together with the RF positive polyarthritis and psoriatic
arthritis subtypes (Figure 2a and b). Analysis with just
the RF negative polyarthritis and oligoarthritis subtypes
showed no association for either rs11836136 (ptrend=0.3)
or rs7957619 (ptrend=0.12). Conversely, analysis of the
UK dataset with all the other subtypes (systemics, RF posi-
tive polyarthritis, enthesitis related arthritis and psoriatic
JIA) showed association with rs11836136 (ptrend=0.005)
and rs7957619 (ptrend=0.02). Therefore, this represents
evidence for subtype specific associations. This is an inter-
esting finding in itself as it provides further genetic
evidence that the SoJIA cases are different to the other
subtypes. Further investigations into the genetics of indi-
vidual subtypes of JIA are required however, power is a
big issue as stratification by subtype inevitably leads to small
sample sizes. The lack of, or weak, association of these
SNPs in the oligoarthritis and RF negative polyarthritis sub-
types in the initial cohort may have been due to a lack of
power and so investigating another cohort of US JIA
cases and controls was appropriate. This approach has
strengthened the evidence that these finding represent
subtype specific effects. Independent validation of the
finding in SoJIA is still required in other datasets.
The MVK gene encodes for mevalonate kinase, an
enzyme that plays a key role in steroid synthesis. It ca-
talyses the conversion of mevalonic acid to 5-phos-
phomevalonic acid, and mutations in this gene are
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a
b
Figure 2 Odds ratio and 95% CI plots for MVK SNPs in UK JIA. Allele frequencies for each JIA subtype separately was compared with that of
the controls and the OR and 95% CI plotted. In addition, the comparison versus the total UK JIA cohort (All JIA) is also shown. For both rs7957619
(Figure 2a) and for rs11836136 (Figure 2b) ILAR 234 comprising of persistent oligoarticular, extended oligoarticular and RF-ve polyarticular JIA,
which represents those JIA subtypes included in the USA validation cohort, are not significantly associated with UK JIA. ILAR 1567 comprises the
systemic onset, RF+ve polyarticular, enthesitis and psoriatic subtypes respectively.
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and the more severe mevalonic aciduria [14,23]. The
pathogenesis of HIDS is not completely clear, but despite
very high levels of IgD seen in this disease, it is thought this
is unlikely to exert a direct pathological effect. More likely
it is a reduction in levels of isoprenoids, anti-inflammatory
compounds produced downstream from MVK in the ster-
oid synthesis pathway that causes the proinflammatory
phenotype seen in HIDS [14]. Experimental models have
shown that lack of isoprenoids in HIDS causes an increase
in the secretion of the proinflammatory cytokine IL-1β
[24,25]. The rs7957619 SNP associated with UK JIA is ex-
onic and changes an amino acid (from Serine toAsparagine). Once replication of the genetic association
has been achieved functional analysis of this coding SNP
should be undertaken to determine if this variation alters
the quality or quantity of the resulting MVK protein and if
any downstream effects on steroid synthesis results.
We also found association of a SNP close to TNFRSF1A.
TNFSR1A encodes the p55 (type-1) TNF receptor (TNFR1),
which plays a vital role in regulating the innate immune sys-
tem via TNF-α signaling, resulting in downstream cytokine
secretion, NF-kB activation, and apoptosis. The rs2228576
SNP lies 3’ of TNFRSF1A, within exon 13 of SCNN1A. The
SNP results in a Threonine to Alanine amino acid change.
The SCNN1A gene itself, which is primarily involved in
Table 2 MVK SNPs investigated for association in the US cohort
SNP CHR Position Gene Major allele
(allele 1)
Minor allele
(allele 2)
MAF
Case
MAF
Control
pHWE
Control
Case genotype frequencies Control genotype frequencies Odds
ratio
95% CI
1/1 (%) 1/2 (%) 2/2 (%) 1/1 (%) 1/2 (%) 2/2 (%) p-value
rs888193* 12 109987576 MVK G C 0.25 0.26 0.22 450 313 41 1679 1148 220 0.22 0.92
(56.0) (38.9) (5.1) (55.1) (37.7) (7.2) 0.81-1.05
rs7957619 12 110013879 MVK G A 0.10 0.12 0.67 653 150 9 2358 650 48 0.04 0.83
(80.4) (18.5) (1.1) (77.2) (21.3) (1.6) 0.7-0.99
* rs888193 is a perfect proxy (r2=1) for rs11836136.
CHR=chromosome, MAF=minor allele frequency, CI=confidence interval, pHWE=p-value for departure from Hardy-Weinburg equilibrium.
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http://www.ped-rheum.com/content/11/1/14sodium and water transport across epithelia, seems an un-
likely gene to have functional relevance in JIA. However,
once replicated, the ability of rs2228576 to regulate
TNFSR1A function could be determined using chromosome
conformation capture techniques [26,27]. This would have
direct relevance to JIA disease pathogenesis. We found asso-
ciation of a SNP in the IL1A gene with the total UK JIA
dataset. Stratification of this SNP by ILAR subtype however,
again showed that this was largely driven by association in
the SoJIA subtype. It is important to point out that there is
almost complete overlap between the SoJIA cases studied
here and by Stock et al. [18]. Therefore, the IL1 ligand and
receptor SNP associations described with SoJIA herein are
not independent validation of Stock’s findings. However, our
data does provide evidence to suggest that the IL1 ligand
and receptor SNP associations are subtype specific, being as-
sociated primarily with SoJIA, and possibly also with the
psoriatic JIA subtype. Interestingly, there was a trend also to-
wards significance with the MVK rs7957619 (p=0.08) and
rs11836136 (p=0.06) SNPs with psoriatic JIA. The numbers
in this subtype are small and independent replication is
required however, it is intriguing that trends towards associ-
ation with additional autoinflammatory disease loci and
psoriatic JIA subtype are occurring, especially as we have
previously reported significant association with SNPs in the
autoinflammatory disease genes NLRP3, NOD2, MEFV and
PSTPIP1 with psoriatic JIA [7].
Magitta et al. previously found no association with
two SNPs in NLRP1 when 505 Norwegian JIA cases were
studied [13]. We have conducted a comprehensive SNP
analysis of the whole NLRP1 gene, and its 5’ and 3’
flanking regions and found no association with UK JIA.
Although JIA is the most common rheumatic disease of
childhood, it is nevertheless extremely rare, making large
cohorts difficult to collect. This makes small sample sizes
a continuing problem across all JIA research, especially re-
search focused on the less common subtype presentations.
Here we have used the largest cohort of JIA available in
Europe, and utilised data from the Welcome Trust Case
Control Consortium to provide control genotype data, to
maximise study power. We have identified association to
SNPs in three genes that appear to be specific with SoJIA,
highlighting that there are genetic as well as clinical differ-
ences between SoJIA and the other JIA subtypes.
Conclusions
1. We have found preliminary evidence of association
of SNPs in MVK, 3’ of TNFRSF1A, and in IL1A
genes with UK SoJIA, further establishing the
genetic as well as clinical differences between SoJIA
and the other JIA subtypes.
2. Further studies in other JIA cohorts should be
performed to replicate these findings.Additional file
Additional file 1: Table S1. Association analysis of all SNPs studied.
Table S2. Association analysis for all SNPs in systemic onset, persistent
oligoarthritis and extended oligoarthritis subtypes. Table S3. Association
analysis for all SNPs in RF –ve polyarthritis, RF +ve polyarthritis and
enthesitis related JIA subtypes. Table S4. Association analysis for all SNPs
in Psoriatic JIA subtype. Table S5. Association analysis in JIA cases (not
including systemic JIA cases) and controls for SNPs in IL1 ligand cluster
and IL1 receptor.
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